Patient characteristics at baseline
| Characteristic . | N = 58 . |
|---|---|
| Male, n (%) | 27 (47) |
| Age | |
| Median (IQR), years | 71 (68-75) |
| ≥75 years, n (%) | 17 (29) |
| ISS stage, n (%) | |
| I | 16 (28) |
| II | 19 (33) |
| III | 23 (40) |
| Creatinine clearance, mL/min, n (%) | |
| <30 | 2 (3) |
| 30-60 | 29 (50) |
| >60 | 27 (47) |
| Chromosomal abnormalities, n (%) | |
| t(4;14) | 9 (16) |
| t(14;16) | 1 (2) |
| Del 17 | 8 (14) |
| Unfavorable profile* | 18 (31) |
| Data missing | 7 (12) |
| Characteristic . | N = 58 . |
|---|---|
| Male, n (%) | 27 (47) |
| Age | |
| Median (IQR), years | 71 (68-75) |
| ≥75 years, n (%) | 17 (29) |
| ISS stage, n (%) | |
| I | 16 (28) |
| II | 19 (33) |
| III | 23 (40) |
| Creatinine clearance, mL/min, n (%) | |
| <30 | 2 (3) |
| 30-60 | 29 (50) |
| >60 | 27 (47) |
| Chromosomal abnormalities, n (%) | |
| t(4;14) | 9 (16) |
| t(14;16) | 1 (2) |
| Del 17 | 8 (14) |
| Unfavorable profile* | 18 (31) |
| Data missing | 7 (12) |
Unfavorable profile was defined as the presence of t(4;14) or t(14;16) or deletion of chromosome 17.